- Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor. Holdhoff, M., Kreuzer, K.A., Appelt, C., Scholz, R., Na, I.K., Hildebrandt, B., Riess, H., Jordan, A., Schmidt, C.A., Van Etten, R.A., Dörken, B., le Coutre, P. Blood Cells Mol. Dis. (2005)